This inventor holds 1 USPTO granted patent. Top assignee: Chapman University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Khalid Zoghebi: Innovator in Targeted Drug Delivery Systems
Introduction
Khalid Zoghebi is an accomplished inventor based in Orange, California. He has made significant contributions to the field of drug delivery systems, particularly in the development of targeted peptide-drug conjugates. His innovative work aims to enhance the efficacy of chemotherapeutic agents in cancer treatment.
Latest Patents
Khalid Zoghebi holds a patent for "Targeted peptide-drug conjugates." This patent describes drug delivery systems that comprise a peptide targeting agent and a pharmaceutical agent for the delivery of chemotherapeutic agents. The methods outlined in the patent focus on treating cancer through the administration of the disclosed drug delivery system.
Career Highlights
Zoghebi is affiliated with Chapman University, where he continues to advance research in drug delivery technologies. His work is pivotal in bridging the gap between basic research and clinical applications, particularly in oncology.
Collaborations
Khalid Zoghebi collaborates with notable colleagues, including Keykavous Parang and Rakesh Tiwari. These partnerships enhance the research and development of innovative solutions in the medical field.
Conclusion
Khalid Zoghebi's contributions to targeted drug delivery systems represent a significant advancement in cancer treatment. His innovative approach and collaboration with esteemed colleagues continue to pave the way for future breakthroughs in medical science.